Dr. Paul Janssen Award for Biomedical Research
The Dr. Paul Janssen Award for Biomedical Research is given annually by Johnson & Johnson to honor the work of an active scientist in academia, industry or a scientific institute in the field of biomedical research. It was established in 2004 and perpetuates the memory of Paul Janssen, the founder of Janssen Pharmaceutica, a Johnson & Johnson subsidiary. The Award. The Dr. Paul Janssen Award includes a $200,000 prize and acknowledges the work of an individual who has made a significant, transformational contribution toward the improvement of human health. Johnson & Johnson created the award  in 2004 with the following goals: Paul Adriaan Jan Janssen (1926–2003). Known to his colleagues as “Dr. Paul,” Janssen was the founder of Janssen Pharmaceutica, N.V., a pharmaceutical research laboratory based in Beerse, Belgium, and a physician-scientist who helped save millions of lives through his contribution to the discovery and development of more than 80 medicines. His work was responsible for many breakthroughs in several fields of disease, including pain management, psychiatry, infectious disease and gastroenterology. In addition, he has more than 100 patents to his name. Selection Process. The award recipients are selected by an independent committee of  scientists from leading academic and scientific institutions, whose own research contributions have resulted in critical advances in improving human health. The 2010 Selection Committee includes past Nobel Laureates, members of the National Academy of Sciences and previous winners of The Dr. Paul Janssen Award. The Selection Committee chooses a scientist in basic or clinical research, who: The award can be given to a scientist in academia, government, industry, a private research institution or medical or clinical practice. It typically will recognize an individual scientist, but can be shared if the contributions of the nominees are considered to have similar importance . Recipients. Source: Jannsen